Cocrystal Pharma focuses on developing and commercializing novel antiviral therapeutics for the treatment of chronic viral diseases. Read more

7 Followers on Owler
7 Followers on Owler
7 Followers on Owler
7 Followers on Owler

Cocrystal Pharma focuses on developing and commercializing novel antiviral therapeutics for the treatment of chronic viral diseases. Read more

Gary L. Wilcox's photo - Chairman & CEO of Cocrystal Pharma

Chairman & CEO

Gary L. Wilcox

CEO Approval Rating

86/100

Founded:

2006

Status:

PublicIndependent CompanyNASDAQCOCP

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Prosetta is perceived as one of Cocrystal Pharma's biggest rivals. Prosetta was founded in 2002, and its headquarters is in San Francisco, California. Prosetta competes in the Biotechnology field. Prosetta has 190 more employees than Cocrystal Pharma.

Agenovir Corporation is one of Cocrystal Pharma's top rivals. Agenovir Corporation is a Private company that was founded in 2014 in South San Francisco, California. Agenovir Corporation operates in the Biotechnology industry. Compared to Cocrystal Pharma, Agenovir Corporation has 36 more employees.

NexImmune is Cocrystal Pharma's #3 rival. NexImmune is a Private company that was founded in Gaithersburg, Maryland in 2011. NexImmune is in the Biotechnology industry. NexImmune has 34 more employees vs. Cocrystal Pharma.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Jounce a competitor of Cocrystal Pharma?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.9M

Cocrystal Pharma's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 62M. Over the last four quarters, Cocrystal Pharma's revenue has grown by 21.6%. Specifically, in Q3 2020's revenue was $ < 1M; in Q2 2020, it was $ < 1M; in Q1 2020, it was $ < 1M; in Q4 2019, Cocrystal Pharma's revenue was $ < 1M.

Acquisitions

No recent acquisitions found related to Cocrystal Pharma

Cocrystal Pharma Funding History

$3.5M$7.2M$13.5M$16.3M$25.3M$28.3M

Since Cocrystal Pharma was founded in 2006, it has participated in 15 rounds of funding. In total Cocrystal Pharma has raised $28.3M. Cocrystal Pharma's last funding round was on Apr 2017 for a total of $3.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Apr 2017
$3M
-
Equity
Aug 2016
$4M
-
Equity
Mar 2016
$5M
-
Equity
Jan 2014
$2.8M
-
Equity
Oct 2013
$3.5M
-

Since Cocrystal Pharma was founded in 2006, it has participated in 15 rounds of funding. In total Cocrystal Pharma has raised $28.3M. Cocrystal Pharma's last funding round was on Apr 2017 for a total of $3.0M

Investments

No recent investments found related to Cocrystal Pharma

Cocrystal Pharma News

November 16, 2020MarketScreener

Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs

(marketscreener.com) - Continued progress of COVID-19 development programs with additional preclinica... See more »
October 19, 2020Markets Insider

Cocrystal Pharma Provides Update on Influenza A Program | Markets Insider

- New in vitro data demonstrating antiviral activity with lead compound CC-42344 against Xofluza (bal... See more »
October 5, 2020MarketScreener

Investor Presentation

(marketscreener.com) NASDAQ: COCP cocrystalpharma.com Investor Presentation October 2020 ...https://w... See more »
October 4, 2020Zolmax News

Cocrystal Pharma (COCP) versus Its Peers

Cocrystal Pharma (NASDAQ: COCP) is one of 710 publicly-traded companies in the "Pharmaceutical prepar... See more »
September 7, 2020Benzinga

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Cocrystal Pharma, Inc. and/or BioZone Pharmaceuticals, Inc. - COCP

NEWARK, N.J., Sept. 07, 2020 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United S... See more »

Cocrystal Pharma Press Releases

January 5, 2021GlobalNewswire

Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

BOTHELL, Wash., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal"... See more »
November 10, 2020GlobeNewswire

Cocrystal Pharma Selected to Present at the World Antiviral Conference

BOTHELL, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), ("Cocrystal" or... See more »
November 6, 2020GlobeNewswire

Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference

- Live video webcast with the Cocrystal management team, on Thursday, November 12th at 12:00 PM EST -... See more »
September 8, 2020GlobalNewswire

Cocrystal Pharma to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

- Live video webcast with Chairman and CEO, Dr. Gary Wilcox, on Monday, September 14th at 3:30 PM EDT... See more »
August 31, 2020centralcharts

Cocrystal Pharma Announces Closing of $17.2 Million Bought Deal Including Partial Exercise of Underwriter's Option to Purchase Additional Shares

BOTHELL, WA, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), ("Cocrystal" or... See more »
August 4, 2020centralcharts

Cocrystal Pharma Announces the Publication by Collaborators of Positive Data Demonstrating Potent In Vitro Inhibition Against Coronavirus in Science Translational Medicine Journal

- Cocrystal has two exclusive licenses for the coronavirus protease inhibitors described in the publi... See more »
May 14, 2020centralcharts

Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs

- Company has sufficient capital to advance pipeline and fund operations through 2021 - BOTHELL, WA, ... See more »

Social Media

Headquarters

19805 N. Creek Parkway

Bothell, Washington98011

877-262-7123

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Cocrystal Pharma focuses on developing and commercializing novel antiviral therapeutics for the treatment of chronic viral diseases. Cocrystal Pharma was founded in 2006. Cocrystal Pharma's headquarters is located in Bothell, Washington, USA 98011. It...

CEO

Cocrystal Pharma's Chairman & CEO, Gary L. Wilcox, currently has an approval rating of 86%. Cocrystal Pharma's primary competitors are Prosetta, Agenovir Corporation & NexImmune.

Website

cocrystalpharma.com

Frequently Asked Questions about Cocrystal Pharma

  1. When was Cocrystal Pharma founded?

    Cocrystal Pharma was founded in 2006
  2. Who is Cocrystal Pharma's CEO?

    Cocrystal Pharma's CEO is Gary L. Wilcox
  3. How much revenue does Cocrystal Pharma generate?

    Cocrystal Pharma generates $1.9M in revenue
  4. How much funding does Cocrystal Pharma have?

    Cocrystal Pharma has historically raised $28.3M in funding
  1. Where is Cocrystal Pharma's headquarters?

    Cocrystal Pharma's headquarters is in Bothell Washington, USA
  2. How many employees does Cocrystal Pharma have?

    Cocrystal Pharma has 10 employees
  3. Who are Cocrystal Pharma's competitors?

    Cocrystal Pharma's top competitors are Prosetta, Agenovir Corporation, NexImmune